NCT04113889View on ClinicalTrials.gov

Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

January 30, 2020

Study Completion Date

January 30, 2020

Conditions
PCOS
Interventions
DRUG

Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily)

72 patients with PCOS receiving metformin, pioglitazone and Acetyl L-Carnitine 500 mg, 15 mg and 1.5 gm BD daily respectively.

DRUG

Metformin, pioglitazone and placebo

72 patients with PCOS receiving metformin, pioglitazone and placebo 500 mg, 15 mg and placebo BD daily respectively.

Trial Locations (1)

25000

Gynecology and Obstetric, Hayatabad Medical Complex, Peshawar

All Listed Sponsors
lead

Khyber Medical University Peshawar

OTHER

NCT04113889 - Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome | Biotech Hunter | Biotech Hunter